Back to today’s briefing

Story perspectives

Wegovy Launches in New Zealand: Weight Loss Breakthrough

6/26/2025

46 4

Summary

Story summary

Novo Nordisk is set to introduce Wegovy in New Zealand on July 1. This groundbreaking weekly injection mimics the hormone GLP-1, promoting a sense of fullness and supporting weight loss while lowering the risk of diabetes and heart disease. However, users should be prepared for a monthly cost of $450-$600 and possible side effects, including nausea.

1 of 1

Story summary

Novo Nordisk is set to introduce Wegovy in New Zealand on July 1. This groundbreaking weekly injection mimics the hormone GLP-1, promoting a sense of fullness and supporting weight loss while lowering the risk of diabetes and heart disease. However, users should be prepared for a monthly cost of $450-$600 and possible side effects, including nausea.